Funding
Seed · Biotech

Blank Bio raises $7.2M seed round

Blank Bio raised $7.2 million in seed financing announced in May.

Updated Oct 16, 2026By RoundOS Funding desk

Define Ventures, SignalFire, Leonis Capital, Ripple Ventures, Nova Threshold, Y Combinator and Pacific Biosciences are among its investors.

The company trains RNA foundation models on tumor transcriptomes for patient-level prediction in oncology.

Funding history

Seed · This round$7.2M

Sources

  1. Blank Bioprojectstartups.com
  2. businesswire.com

Similar rounds

All Biotech rounds →
Guoke Brain-Computer

Beijing startup developing non-invasive wearable brain-computer interfaces that combine brain-signal detection, decoding and neural modulation.

UndisclosedSeed · Oct 23, 2026
Star Therapeutics

Biotechnology company discovering and developing antibody therapies for diseases with significant unmet need.

$200MPrivate financing · Oct 23, 2026
Pathos AI

Clinical-stage drug developer using AI to select therapeutic assets and guide oncology trials.

$237MSeries E · Oct 23, 2026
Knowledge Work

Tokyo software company developing sales AI agents, an agent operating platform and consulting services for enterprise sales teams.

¥4.8BSeries C debt second close · Oct 23, 2026

Related